AXIL posts y/y earnings growth, with dips in revenues and profits in Q2. Yet, a stronger cash position and growth initiatives offer optimism....
The deal is expected to close in Q1 2025, subject to regulatory approvals....
We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are going to take a look at where Rigetti Computing, Inc. (NASDAQ:RGTI) stands a...
Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro....
Intense Competition and Inventory Shortfalls Drive Pharmaceutical Giant's Revenue Cut...
Bad news for Eli Lilly (NYSE: LLY) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated investors on its expected revenue for 2024 this morning, an...
Fannie Mae's latest report reveals unexpected growth as supply shortages fuel fierce competition among buyers....